ID   S47A2_HUMAN             Reviewed;         602 AA.
AC   Q86VL8; A0JBX9; A0P8Z7; Q63HJ9; Q8IV44; Q96NA1;
DT   04-DEC-2007, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-2003, sequence version 1.
DT   15-MAR-2017, entry version 112.
DE   RecName: Full=Multidrug and toxin extrusion protein 2;
DE            Short=MATE-2;
DE            Short=hMATE-2;
DE   AltName: Full=Kidney-specific H(+)/organic cation antiporter;
DE   AltName: Full=Solute carrier family 47 member 2;
GN   Name=SLC47A2; Synonyms=MATE2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 3 AND 6), TISSUE SPECIFICITY,
RP   FUNCTION, AND BIOPHYSICOCHEMICAL PROPERTIES.
RC   TISSUE=Brain, and Kidney;
RX   PubMed=16807400; DOI=10.1681/ASN.2006030205;
RA   Masuda S., Terada T., Yonezawa A., Tanihara Y., Kishimoto K.,
RA   Katsura T., Ogawa O., Inui K.;
RT   "Identification and functional characterization of a new human kidney-
RT   specific H+/organic cation antiporter, kidney-specific multidrug and
RT   toxin extrusion 2.";
RL   J. Am. Soc. Nephrol. 17:2127-2135(2006).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 5).
RC   TISSUE=Kidney;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Small intestine;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H.,
RA   Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K.,
RA   Ottenwaelder B., Poustka A., Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 4).
RC   TISSUE=Colon;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   FUNCTION.
RX   PubMed=16996621; DOI=10.1016/j.tips.2006.09.001;
RA   Omote H., Hiasa M., Matsumoto T., Otsuka M., Moriyama Y.;
RT   "The MATE proteins as fundamental transporters of metabolic and
RT   xenobiotic organic cations.";
RL   Trends Pharmacol. Sci. 27:587-593(2006).
RN   [7]
RP   FUNCTION, AND BIOPHYSICOCHEMICAL PROPERTIES.
RX   PubMed=17509534; DOI=10.1016/j.bcp.2007.04.010;
RA   Tanihara Y., Masuda S., Sato T., Katsura T., Ogawa O., Inui K.;
RT   "Substrate specificity of MATE1 and MATE2-K, human multidrug and toxin
RT   extrusions/H(+)-organic cation antiporters.";
RL   Biochem. Pharmacol. 74:359-371(2007).
CC   -!- FUNCTION: Solute transporter for tetraethylammonium (TEA), 1-
CC       methyl-4-phenylpyridinium (MPP), cimetidine, N-methylnicotinamide,
CC       metformin, creatinine, guanidine, procainamide, topotecan, estrone
CC       sulfate, acyclovir, and ganciclovir. Responsible for the secretion
CC       of cationic drugs across the brush border membranes.
CC       {ECO:0000269|PubMed:16807400, ECO:0000269|PubMed:16996621,
CC       ECO:0000269|PubMed:17509534}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=0.76 mM for TEA {ECO:0000269|PubMed:16807400,
CC         ECO:0000269|PubMed:17509534};
CC         KM=0.11 mM for MPP {ECO:0000269|PubMed:16807400,
CC         ECO:0000269|PubMed:17509534};
CC         KM=0.12 mM for cimetidine {ECO:0000269|PubMed:16807400,
CC         ECO:0000269|PubMed:17509534};
CC         KM=1.98 mM for metformin {ECO:0000269|PubMed:16807400,
CC         ECO:0000269|PubMed:17509534};
CC         KM=4.2 mM for guanidine {ECO:0000269|PubMed:16807400,
CC         ECO:0000269|PubMed:17509534};
CC         KM=1.58 mM for procainamide {ECO:0000269|PubMed:16807400,
CC         ECO:0000269|PubMed:17509534};
CC         KM=0.06 mM for topotecan {ECO:0000269|PubMed:16807400,
CC         ECO:0000269|PubMed:17509534};
CC         KM=0.85 mM for estrone sulfate {ECO:0000269|PubMed:16807400,
CC         ECO:0000269|PubMed:17509534};
CC         KM=4.32 mM for acyclovir {ECO:0000269|PubMed:16807400,
CC         ECO:0000269|PubMed:17509534};
CC         KM=4.28 mM for ganciclovir {ECO:0000269|PubMed:16807400,
CC         ECO:0000269|PubMed:17509534};
CC         Vmax=0.88 nmol/min/mg enzyme toward TEA
CC         {ECO:0000269|PubMed:16807400, ECO:0000269|PubMed:17509534};
CC         Vmax=0.575 nmol/min/mg enzyme toward MPP
CC         {ECO:0000269|PubMed:16807400, ECO:0000269|PubMed:17509534};
CC         Vmax=0.115 nmol/min/mg enzyme toward cimetidine
CC         {ECO:0000269|PubMed:16807400, ECO:0000269|PubMed:17509534};
CC         Vmax=0.845 nmol/min/mg enzyme toward metformin
CC         {ECO:0000269|PubMed:16807400, ECO:0000269|PubMed:17509534};
CC         Vmax=0.58 nmol/min/mg enzyme toward guanidine
CC         {ECO:0000269|PubMed:16807400, ECO:0000269|PubMed:17509534};
CC         Vmax=3.385 nmol/min/mg enzyme toward procainamide
CC         {ECO:0000269|PubMed:16807400, ECO:0000269|PubMed:17509534};
CC         Vmax=0.13 nmol/min/mg enzyme toward topotecan
CC         {ECO:0000269|PubMed:16807400, ECO:0000269|PubMed:17509534};
CC         Vmax=0.425 nmol/min/mg enzyme toward estrone sulfate
CC         {ECO:0000269|PubMed:16807400, ECO:0000269|PubMed:17509534};
CC         Vmax=0.945 nmol/min/mg enzyme toward acyclovir
CC         {ECO:0000269|PubMed:16807400, ECO:0000269|PubMed:17509534};
CC         Vmax=0.805 nmol/min/mg enzyme toward ganciclovir
CC         {ECO:0000269|PubMed:16807400, ECO:0000269|PubMed:17509534};
CC       pH dependence:
CC         Optimum pH is 9.0. Active from pH 6 to 9.
CC         {ECO:0000269|PubMed:16807400, ECO:0000269|PubMed:17509534};
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000305}; Multi-pass
CC       membrane protein {ECO:0000305}. Note=Localized at the brush border
CC       membranes of the proximal tubules.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=6;
CC       Name=1;
CC         IsoId=Q86VL8-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q86VL8-2; Sequence=VSP_029656, VSP_029658, VSP_029663,
CC                                  VSP_029664;
CC         Note=No experimental confirmation available.;
CC       Name=3; Synonyms=MATE2-K;
CC         IsoId=Q86VL8-3; Sequence=VSP_029658;
CC         Note=No experimental confirmation available.;
CC       Name=4;
CC         IsoId=Q86VL8-4; Sequence=VSP_029658, VSP_029662;
CC         Note=No experimental confirmation available.;
CC       Name=5;
CC         IsoId=Q86VL8-5; Sequence=VSP_029658, VSP_029660, VSP_029661;
CC         Note=No experimental confirmation available.;
CC       Name=6; Synonyms=MATE2-B;
CC         IsoId=Q86VL8-6; Sequence=VSP_029657, VSP_029659;
CC         Note=Inactive. Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Isoform 3 is predominantly expressed in
CC       kidney. Isoform 6 is expressed in brain.
CC       {ECO:0000269|PubMed:16807400}.
CC   -!- SIMILARITY: Belongs to the multi antimicrobial extrusion (MATE)
CC       (TC 2.A.66.1) family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AB250364; BAF36847.1; -; mRNA.
DR   EMBL; AB250701; BAF37007.1; -; mRNA.
DR   EMBL; AK055758; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; BX648861; CAH56154.1; -; mRNA.
DR   EMBL; CH471212; EAW50902.1; -; Genomic_DNA.
DR   EMBL; CH471212; EAW50904.1; -; Genomic_DNA.
DR   EMBL; CH471212; EAW50905.1; -; Genomic_DNA.
DR   EMBL; BC035288; AAH35288.1; -; mRNA.
DR   EMBL; BC050578; AAH50578.1; -; mRNA.
DR   CCDS; CCDS11211.1; -. [Q86VL8-1]
DR   CCDS; CCDS58530.1; -. [Q86VL8-4]
DR   RefSeq; NP_001093116.1; NM_001099646.1. [Q86VL8-3]
DR   RefSeq; NP_001243592.1; NM_001256663.1. [Q86VL8-4]
DR   RefSeq; NP_690872.2; NM_152908.3. [Q86VL8-1]
DR   UniGene; Hs.126830; -.
DR   ProteinModelPortal; Q86VL8; -.
DR   MINT; MINT-4723030; -.
DR   STRING; 9606.ENSP00000326671; -.
DR   BindingDB; Q86VL8; -.
DR   ChEMBL; CHEMBL1743127; -.
DR   DrugBank; DB00787; Aciclovir.
DR   GuidetoPHARMACOLOGY; 1217; -.
DR   TCDB; 2.A.66.1.20; the multidrug/oligosaccharidyl-lipid/polysaccharide (mop) flippase superfamily.
DR   iPTMnet; Q86VL8; -.
DR   PhosphoSitePlus; Q86VL8; -.
DR   BioMuta; SLC47A2; -.
DR   DMDM; 74727585; -.
DR   PaxDb; Q86VL8; -.
DR   PeptideAtlas; Q86VL8; -.
DR   PRIDE; Q86VL8; -.
DR   Ensembl; ENST00000325411; ENSP00000326671; ENSG00000180638. [Q86VL8-1]
DR   Ensembl; ENST00000350657; ENSP00000338084; ENSG00000180638. [Q86VL8-4]
DR   Ensembl; ENST00000574239; ENSP00000458694; ENSG00000180638. [Q86VL8-6]
DR   GeneID; 146802; -.
DR   KEGG; hsa:146802; -.
DR   UCSC; uc002gwe.5; human. [Q86VL8-1]
DR   CTD; 146802; -.
DR   DisGeNET; 146802; -.
DR   GeneCards; SLC47A2; -.
DR   H-InvDB; HIX0039367; -.
DR   HGNC; HGNC:26439; SLC47A2.
DR   MIM; 609833; gene.
DR   neXtProt; NX_Q86VL8; -.
DR   OpenTargets; ENSG00000180638; -.
DR   PharmGKB; PA162403847; -.
DR   eggNOG; KOG1347; Eukaryota.
DR   eggNOG; COG0534; LUCA.
DR   GeneTree; ENSGT00390000015713; -.
DR   HOGENOM; HOG000060313; -.
DR   HOVERGEN; HBG056043; -.
DR   InParanoid; Q86VL8; -.
DR   KO; K03327; -.
DR   OMA; IVACYHV; -.
DR   OrthoDB; EOG091G06X2; -.
DR   PhylomeDB; Q86VL8; -.
DR   TreeFam; TF324441; -.
DR   Reactome; R-HSA-425366; Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds.
DR   GeneWiki; SLC47A2; -.
DR   GenomeRNAi; 146802; -.
DR   PRO; PR:Q86VL8; -.
DR   Proteomes; UP000005640; Chromosome 17.
DR   Bgee; ENSG00000180638; -.
DR   CleanEx; HS_SLC47A2; -.
DR   ExpressionAtlas; Q86VL8; baseline and differential.
DR   Genevisible; Q86VL8; HS.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0015307; F:drug:proton antiporter activity; TAS:Reactome.
DR   GO; GO:0055085; P:transmembrane transport; TAS:Reactome.
DR   InterPro; IPR002528; MATE_fam.
DR   Pfam; PF01554; MatE; 2.
DR   TIGRFAMs; TIGR00797; matE; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Cell membrane; Complete proteome; Membrane;
KW   Polymorphism; Reference proteome; Transmembrane; Transmembrane helix;
KW   Transport.
FT   CHAIN         1    602       Multidrug and toxin extrusion protein 2.
FT                                /FTId=PRO_0000311952.
FT   TOPO_DOM      1     33       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM     34     54       Helical. {ECO:0000255}.
FT   TOPO_DOM     55     66       Extracellular. {ECO:0000255}.
FT   TRANSMEM     67     87       Helical. {ECO:0000255}.
FT   TOPO_DOM     88    119       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    120    140       Helical. {ECO:0000255}.
FT   TOPO_DOM    141    153       Extracellular. {ECO:0000255}.
FT   TRANSMEM    154    174       Helical. {ECO:0000255}.
FT   TOPO_DOM    175    219       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    220    240       Helical. {ECO:0000255}.
FT   TOPO_DOM    241    248       Extracellular. {ECO:0000255}.
FT   TRANSMEM    249    269       Helical. {ECO:0000255}.
FT   TOPO_DOM    270    289       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    290    309       Helical. {ECO:0000255}.
FT   TOPO_DOM    310    327       Extracellular. {ECO:0000255}.
FT   TRANSMEM    328    348       Helical. {ECO:0000255}.
FT   TOPO_DOM    349    368       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    369    389       Helical. {ECO:0000255}.
FT   TOPO_DOM    390    402       Extracellular. {ECO:0000255}.
FT   TRANSMEM    403    423       Helical. {ECO:0000255}.
FT   TOPO_DOM    424    442       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    443    463       Helical. {ECO:0000255}.
FT   TOPO_DOM    464    466       Extracellular. {ECO:0000255}.
FT   TRANSMEM    467    487       Helical. {ECO:0000255}.
FT   TOPO_DOM    488    578       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    579    599       Helical. {ECO:0000255}.
FT   TOPO_DOM    600    602       Extracellular. {ECO:0000255}.
FT   COMPBIAS    508    511       Poly-Gln.
FT   VAR_SEQ       1     49       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:17974005}.
FT                                /FTId=VSP_029656.
FT   VAR_SEQ     178    219       GWLKGQEEESPFQTPGLSILHPSHSHLSRASFHLFQKITWP
FT                                Q -> AGERLCVPASSNSSTGMAEGAGGGVPIPNPGFVHPP
FT                                SISLTP (in isoform 6).
FT                                {ECO:0000303|PubMed:16807400}.
FT                                /FTId=VSP_029657.
FT   VAR_SEQ     178    213       Missing (in isoform 2, isoform 3, isoform
FT                                4 and isoform 5).
FT                                {ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|PubMed:16807400,
FT                                ECO:0000303|PubMed:17974005}.
FT                                /FTId=VSP_029658.
FT   VAR_SEQ     220    602       Missing (in isoform 6).
FT                                {ECO:0000303|PubMed:16807400}.
FT                                /FTId=VSP_029659.
FT   VAR_SEQ     317    398       GLLSVVDLSAQAVIYEVATVTYMIPLGLSIGVCVRVGMALG
FT                                AADTVQAKRSAVSGVLSIVGISLVLGTLISILKNQLGHIFT
FT                                -> EHAQCGGSLCPGCHLGGHCDLHDSLGAQHRGLCPSGDG
FT                                SGGRGYCAGQALGRLGRAQHSWHFPGPGHPDKHPEKSAGAY
FT                                FYQ (in isoform 5).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_029660.
FT   VAR_SEQ     339    339       M -> MRHSHRLAYAAHVTR (in isoform 4).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_029662.
FT   VAR_SEQ     376    381       VGISLV -> EMSLPW (in isoform 2).
FT                                {ECO:0000303|PubMed:17974005}.
FT                                /FTId=VSP_029663.
FT   VAR_SEQ     382    602       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:17974005}.
FT                                /FTId=VSP_029664.
FT   VAR_SEQ     399    602       Missing (in isoform 5).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_029661.
FT   VARIANT     429    429       G -> R (in dbSNP:rs34399035).
FT                                /FTId=VAR_037358.
FT   CONFLICT      6      6       D -> E (in Ref. 1; BAF37007).
FT                                {ECO:0000305}.
FT   CONFLICT     23     23       V -> A (in Ref. 2; AK055758).
FT                                {ECO:0000305}.
FT   CONFLICT     93     93       D -> G (in Ref. 2; AK055758).
FT                                {ECO:0000305}.
FT   CONFLICT    284    284       C -> Y (in Ref. 3; CAH56154).
FT                                {ECO:0000305}.
SQ   SEQUENCE   602 AA;  65085 MW;  88EB90286AE701D1 CRC64;
     MDSLQDTVAL DHGGCCPALS RLVPRGFGTE MWTLFALSGP LFLFQVLTFM IYIVSTVFCG
     HLGKVELASV TLAVAFVNVC GVSVGVGLSS ACDTLMSQSF GSPNKKHVGV ILQRGALVLL
     LCCLPCWALF LNTQHILLLF RQDPDVSRLT QDYVMIFIPG LPVIFLYNLL AKYLQNQGWL
     KGQEEESPFQ TPGLSILHPS HSHLSRASFH LFQKITWPQV LSGVVGNCVN GVANYALVSV
     LNLGVRGSAY ANIISQFAQT VFLLLYIVLK KLHLETWAGW SSQCLQDWGP FFSLAVPSML
     MICVEWWAYE IGSFLMGLLS VVDLSAQAVI YEVATVTYMI PLGLSIGVCV RVGMALGAAD
     TVQAKRSAVS GVLSIVGISL VLGTLISILK NQLGHIFTND EDVIALVSQV LPVYSVFHVF
     EAICCVYGGV LRGTGKQAFG AAVNAITYYI IGLPLGILLT FVVRMRIMGL WLGMLACVFL
     ATAAFVAYTA RLDWKLAAEE AKKHSGRQQQ QRAESTATRP GPEKAVLSSV ATGSSPGITL
     TTYSRSECHV DFFRTPEEAH ALSAPTSRLS VKQLVIRRGA ALGAASATLM VGLTVRILAT
     RH
//
